Trial Profile
A Registry-Based Cohort Study Comparing Outcomes of Biodegradable-Polymer Biolimus-Eluting Stents Versus Durable-Polymer Everolimus-Eluting Stents in Percutaneous Coronary Intervention (PCI) Patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 11 Jul 2017
Price :
$35
*
At a glance
- Drugs Everolimus (Primary) ; Umirolimus (Primary)
- Indications Coronary artery disease; Coronary artery restenosis
- Focus Therapeutic Use
- 11 Jul 2017 New trial record